language_icon
EN
HI

Venmax Drugs And Pharmaceuticals Share price

VENMAX

25.98

0.46 (-1.74%)
Last updated on 20 Feb, 2026 | 14:46 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

26.11

Today's Low

23.80

52 Week Low

17.51

52 Week High

36.96

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Venmax Drugs And Pharmaceuticals Chart

Venmax Drugs And Pharmaceuticals Share Key Metrics

Volume
227.00
Market Cap
13.85 CR
LTQ@LTP
10@25.98
ATP
24.51
Var Margin
25.41 %
Circuit Range
23.8-29.08
Delivery %
0 %
Value
5563.77
ASM/GSM
No
Market Lot
1

Summary

At 20 Feb, 2026 | 14:46, Venmax Drugs And Pharmaceuticals share price stands at ₹25.98, showing a 0.46% -1.74 for the day. The stock’s intraday movement has stayed between ₹23.80 and ₹26.11, while on a 52-week basis it has fluctuated from ₹17.51 to ₹36.96.
In terms of trading activity, Venmax Drugs And Pharmaceuticals has recorded a volume of 227 shares, with a market capitalisation of ₹5238930. The stock’s Average Traded Price (ATP) stands at ₹2451, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10,2598. The stock operates within a circuit range of ₹23.8-29.08, with a Value of ₹5563.77. The Delivery Percentage for the day is %. Additionally, Venmax Drugs And Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Venmax Drugs And Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

63.82

Sector P/B

2.76

Sec. Div. Yield

0.57

Venmax Drugs And Pharmaceuticals Resistance and Support

Pivot 26.54

Resistance

First Resistance

28.81

Second Resistance

31.17

Third Resistance

33.44

Support

First Support

24.18

Second Support

21.91

Third Support

19.55

Venmax Drugs And Pharmaceuticals Futures & Options

Data Not Found

Venmax Drugs And Pharmaceuticals Shareholding Pattern

View More
  • 2019-20
  • 2021-22
  • 2023-24
  • 2025-26
  • 2018-19
  • 2024-25
  • 2022-23
  • 2020-21
Total Promoters
Segment
Percent

Total Promoters

23.13%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.15%

Retail

76.72%

Others

0%

Total Promoters
MAR '19
23.14%
JUN '19
23.13%
SEP '19
23.13%
DEC '19
23.13%

Venmax Drugs And Pharmaceuticals Corporate Actions

DateAgenda
2026-02-07Quarterly Results
2025-11-12Quarterly Results
2025-09-02Amalgamation & A.G.M.
2025-08-16Others
2025-07-23Quarterly Results
2025-05-09Audited Results
2025-02-08Quarterly Results
2025-01-11Preferential issue of shares

Venmax Drugs And Pharmaceuticals News

No Data Found

About Venmax Drugs And Pharmaceuticals

NSE : 0  
BSE : 531015  
ISIN : INE154G01022  

Yenkey Drugs and Pharmaceuticals Ltd. was originallyincorporated on 28th September 1988 in the name of YenkeyMedico Drugs Private Limited. The Company has beenconverted into a public limited company on 3rd Feb''95 interms of a special resolution passed on 23.01.95 underSection 31(1)/44 of the Companies Act 1956. Accordinglythe Company has obtained a fresh Certificate ofIncorporation consequent on the conversion from theRegistrar of Companies Andhra Pradesh vide ref. no.01-09102 dated 3rd February 1995.The Company is producing bulk drug intermediates asdetailed above and marketing in the domestic markets. Thetotal turnover of the Company is Rs. 89.70 lacs for theyear ended March 1994. Now the Company proposes to expandthe existing capacity of dye and drug intermediate viz; ECAand diversifying into manufacturing of high value chemicalsand bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate.The Company is also proposing to set up a R & D Unit formaintaining high quality control standards of foreignbuyers.

Read More

Venmax Drugs And Pharmaceuticals Management

NamePosition
Mr. Venkata Rao Sadhanala Whole Time Director
Mrs. Dakshita Jain Addnl.Non Exe.Independent Director
View More

Venmax Drugs And Pharmaceuticals Similar Stocks

No Data Found

Venmax Drugs And Pharmaceuticals FAQs

The Buying Price of Venmax Drugs And Pharmaceuticals share is 25.98 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Venmax Drugs And Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Venmax Drugs And Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Venmax Drugs And Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Venmax Drugs And Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Venmax Drugs And Pharmaceuticals’s valuation compare Sector P/E, P/B which are 63.82 & 2.76 with sector averages, along with growth rates and financial metrics.

The Market Cap of Venmax Drugs And Pharmaceuticals is 13.85 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Venmax Drugs And Pharmaceuticals share price is 36.96 & 17.51. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Venmax Drugs And Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost